Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?

Eur Respir J. 2008 Apr;31(4):904-5. doi: 10.1183/09031936.00159807.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Estonia / epidemiology
  • Fluoroquinolones / pharmacology
  • Fluoroquinolones / therapeutic use*
  • Germany / epidemiology
  • Humans
  • Italy / epidemiology
  • Risk Factors
  • Russia / epidemiology
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / mortality

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones